Chemotherapy resistance of glioblastoma stem cells [2]

Cell Death and Differentiation

Volumn 13, Issue 7, 2006, Pages 1238-1241

  Eramo, A ^a   Ricci Vitiani, L ^a   Zeuner, A ^a,b   Pallini, R ^c   Lotti, F ^b   Sette, G ^b   Pilozzi, E ^d   Larocca, L M ^c   Peschle, C ^a   De Maria, R ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Mediterranean Institute of Oncology   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; DOXORUBICIN; ETOPOSIDE; TEMOZOLOMIDE;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL CLONE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CHEMOSENSITIVITY; CYTOTOXICITY; DRUG EXPOSURE; ERYTHROBLAST; GLIOBLASTOMA; HUMAN; LETTER; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BRAIN NEOPLASMS; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GLIOBLASTOMA; HUMANS; JURKAT CELLS; MICE; MICE, NUDE; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR STEM CELLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33745198882     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401872     Document Type: Letter

References (12)

1. Stupp R et al. (2005) N. Engl. J. Med. 352: 987-996
2. DeAngelis LM (2001) N. Engl. J. Med. 344: 114-123
3. Fulda S et al. (2002) Nat. Med. 8: 808-815
4. Grossman SA and Batara JF (2004) Semin. Oncol. 31: 635-644
5. Bonnet D and Dick JE (1997) Nat. Med. 3: 730-737
6. Al-Hajj M et al. (2003) Proc. Natl. Acad. Sci. USA 100: 3983-3988
7. Galli R et al. (2004) Cancer Res. 64: 7011-7021
8. Singh SK et al. (2004) Nature 432: 396-401
9. Zeuner A et al. (2003) Blood 102: 87-93
10. Dean M, Fojo T and Bates S (2005) Nat. Rev. Cancer 5: 275-284
11. Johnstone RW, Ruefli AA and Lowe SW (2002) Cell 108: 153-164
12. Ricci-Vitiani L et al. (2004) J. Exp. Med. 200: 1257-1266